🇺🇸 FDA
Pipeline program

Colchicine

2025-I2M-C&T-B-026

Unknown small_molecule active

Quick answer

Colchicine for Transcatheter Aortic Valve Replacement is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Transcatheter Aortic Valve Replacement
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials